Literature DB >> 3762918

Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.

W J Fagel, R E Hekster, S J Smith, J C van der Vijver.   

Abstract

A patient is described with a large prolactinoma with expansion into the sphenoid sinus. During bromocriptine treatment an intrasellar area of gas developed, continuous with the air in the sinus. No operation was performed, bromocriptine was continued. During the regression of the tumor, the area of air disappeared.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762918     DOI: 10.1007/bf00333448

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

1.  Collection of gas within a huge chromophobe adenoma. A case report.

Authors:  N Hashimoto; H Handa; J Takeuchi; M Ishikawa; Y Nakano
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

2.  Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas.

Authors:  A M Landolt
Journal:  Neurosurgery       Date:  1982-09       Impact factor: 4.654

3.  Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.

Authors:  R O Holness; A H Shlossberg; L P Heffernan
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

4.  Cerebrospinal fluid rhinorrhoea during treatment of pituitary tumours with bromocriptine.

Authors:  J D Wilson; R L Newcombe; F L Long
Journal:  Acta Endocrinol (Copenh)       Date:  1983-08

5.  Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.

Authors:  D L Barrow; G T Tindall; K Kovacs; M O Thorner; E Horvath; J C Hoffman
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

  5 in total
  1 in total

1.  Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.

Authors:  G Hildebrandt; J Zierski; P Christophis; A Laun; H Schatz; I Lancranjan; N Klug
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.